221 (Januvia 25 mg)

Generic Name: sitagliptin

Pill imprint 221 has been identified as Januvia 25 mg.

Januvia is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Januvia 25 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 221

Januvia 25 mg 221
Januvia 25 mg 221
Januvia
Generic Name:
sitagliptin
Imprint:
221
Strength:
25 mg
Color:
Pink
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Dipeptidyl peptidase 4 inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Merck & Company Inc.
National Drug Code (NDC):
00006-0221
Inactive Ingredients:
calcium phosphate dibasic anhydrous
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
ferric oxide red
sodium stearyl fumarate
magnesium silicate
titanium dioxide
ferric oxide yellow

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)